Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor 1L3 (OR1L3) is a member of the large family of olfactory receptors, which are G protein-coupled receptors responsible for the initial detection of odorants in the nasal olfactory epithelium[5][7]. Like other olfactory receptors, OR1L3 features the characteristic seven-transmembrane domain structure of class A GPCRs and is primarily expressed in sensory neurons of the nose, where it mediates the detection of specific chemical odorants to initiate the sense of smell[4][7]. OR1L3 may also be expressed at low levels in non-olfactory tissues, but its physiological role is best established in olfactory signal transduction. To date, no drugs are known to specifically interact with OR1L3, nor is it associated with major diseases or utilized as a biomarker.
Not applicable (No drugs target OR1L3 directly; odorant molecules bind and activate via classic GPCR mechanisms)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor 1L3 (OR1L3).